Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 79651 - 79675 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Titanium dioxide	Approved	CD46	4179	upregulated	titanium dioxide results in increased expression of CD46 mRNA	1q32.2	A24434
Titanium dioxide	Approved	CD72	971	upregulated	titanium dioxide results in increased expression of CD72 mRNA	9p13.3	A24434
Titanium dioxide	Approved	CDH5	1003	upregulated	[Vitallium analog binds to titanium dioxide] which results in increased expression of CDH5 mRNA	16q21	A24432
Titanium dioxide	Approved	CDK1	983	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of CDK1 mRNA	10q21.2	A24432
Titanium dioxide	Approved	CDK2	1017	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of CDK2 mRNA	12q13.2	A24432
Titanium dioxide	Approved	CDKN1A	1026	upregulated	titanium dioxide results in increased expression of CDKN1A mRNA	6p21.2	A24437
Titanium dioxide	Approved	CDKN2C	1031	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of CDKN2C mRNA	1p32.3	A24432
Titanium dioxide	Approved	CHTF18	63922	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of CHTF18 mRNA	16p13.3	A24432
Titanium dioxide	Approved	CHUK	1147	downregulated	titanium dioxide results in decreased expression of CHUK mRNA	10q24.31	A24217
Titanium dioxide	Approved	CLU	1191	upregulated	titanium dioxide results in increased expression of CLU mRNA	8p21.1	A24434
Titanium dioxide	Approved	COL12A1	1303	upregulated	[Vitallium analog binds to titanium dioxide] which results in increased expression of COL12A1 mRNA	6q13-q14.1	A24432
Titanium dioxide	Approved	COL13A1	1305	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of COL13A1 mRNA	10q22.1	A24432
Titanium dioxide	Approved	COL18A1	80781	upregulated	[Vitallium analog binds to titanium dioxide] which results in increased expression of COL18A1 mRNA	21q22.3	A24432
Titanium dioxide	Approved	CRIM1	51232	upregulated	titanium dioxide results in increased expression of CRIM1 mRNA	2p22.2	A24434
Titanium dioxide	Approved	CSF2	1437	upregulated	titanium dioxide results in increased expression of CSF2 mRNA	5q31.1	A24438 A24434
Titanium dioxide	Approved	CXCL10	3627	upregulated	titanium dioxide results in increased expression of CXCL10 mRNA	4q21.1	A24434
Titanium dioxide	Approved	CXCL11	6373	upregulated	titanium dioxide results in increased expression of CXCL11 mRNA	4q21.1	A24434
Titanium dioxide	Approved	CXCL12	6387	upregulated	titanium dioxide results in increased expression of CXCL12 mRNA	10q11.21	A24434
Titanium dioxide	Approved	CXCL8	3576	upregulated	titanium dioxide results in increased expression of CXCL8 mRNA	4q13.3	A24439
Titanium dioxide	Approved	DDR2	4921	upregulated	titanium dioxide results in increased expression of DDR2 mRNA	1q23.3	A24434
Titanium dioxide	Approved	DDR2	4921	upregulated	[Vitallium analog binds to titanium dioxide] which results in increased expression of DDR2 mRNA	1q23.3	A24432
Titanium dioxide	Approved	DST	667	upregulated	titanium dioxide results in increased expression of DST mRNA	6p12.1	A24434
Titanium dioxide	Approved	FADD	8772	downregulated	titanium dioxide results in decreased expression of FADD mRNA	11q13.3	A24434
Titanium dioxide	Approved	FAS	355	upregulated	titanium dioxide results in increased expression of FAS mRNA	10q23.31	A24434
Titanium dioxide	Approved	FEN1	2237	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of FEN1 mRNA	11q12.2	A24432

Displaying entries 79651 - 79675 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability